Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Misuse of blood serum to assess exposure to bisphenol A and phthalates.

Calafat AM, Koch HM, Swan SH, Hauser R, Goldman LR, Lanphear BP, Longnecker MP, Rudel RA, Teitelbaum SL, Whyatt RM, Wolff MS.

Breast Cancer Res. 2013;15(5):403. No abstract available.

2.

Authors' response.

Sprague BL, Trentham-Dietz A, Hedman CJ, Wang J, Hemming JD, Hampton JM, Buist DS, Bowles EJ, Burnside ES.

Breast Cancer Res. 2013;15(5):403. No abstract available.

PMID:
24592439
3.

Sex hormones and breast cancer risk and prognosis.

Folkerd E, Dowsett M.

Breast. 2013 Aug;22 Suppl 2:S38-43. doi: 10.1016/j.breast.2013.07.007. Review.

PMID:
24074790
4.

A rose without thorns? Neutralizing the vice and magnifying the virtue of conjugated equine estrogens.

Sayegh RA.

Menopause. 2013 Feb;20(2):120-2. doi: 10.1097/gme.0b013e31827dedd3. No abstract available.

PMID:
23340265
5.

Recent findings may inform breast density notification laws.

Trubo R.

JAMA. 2015 Feb 3;313(5):452-3. doi: 10.1001/jama.2014.17914. No abstract available.

PMID:
25647190
6.

Breast-density legislation--practical considerations.

Slanetz PJ, Freer PE, Birdwell RL.

N Engl J Med. 2015 Feb 12;372(7):593-5. doi: 10.1056/NEJMp1413728. No abstract available.

7.

Preeclampsia and subsequent breast cancer risk.

Carbillon L, Delahosseraye C.

Cancer Causes Control. 2015 Jun;26(6):955-6. doi: 10.1007/s10552-015-0577-5. Epub 2015 Apr 10. No abstract available.

PMID:
25860115
8.

Dense breasts and legislating medicine.

Ho N, Kim J, Prasad V.

Cleve Clin J Med. 2013 Dec;80(12):768-70. doi: 10.3949/ccjm.80a.13048. No abstract available.

9.

Breast density, supplemental screening, and a streamlined approach to discussion between a patient and her doctor--a novel, efficient approach.

Brem RF.

Breast J. 2014 May-Jun;20(3):227-8. doi: 10.1111/tbj.12249. No abstract available.

PMID:
24750507
10.

Biomarkers and clinical interventions.

Paradiso A.

Ann Oncol. 2013 Nov;24 Suppl 8:viii36. doi: 10.1093/annonc/mdt314. No abstract available.

11.

The conundrum of explaining breast density to patients.

Marcus EN, Yepes M.

Cleve Clin J Med. 2013 Dec;80(12):761-5. doi: 10.3949/ccjm.80a.13026. No abstract available.

12.

Response to letter to the Editor from Dr. Carbillon on our article about first pregnancy characteristics, genetics, and breast density.

Prebil LA.

Cancer Causes Control. 2015 Jun;26(6):957. doi: 10.1007/s10552-015-0570-z. Epub 2015 Mar 28. No abstract available.

PMID:
25820639
13.

Volparaâ„¢ as a measurement tool for breast volume.

Teo I, Whelehan P, Macaskill JE, Vinnicombe S, Munnoch DA, Evans A.

J Plast Reconstr Aesthet Surg. 2016 Apr;69(4):581-2. doi: 10.1016/j.bjps.2015.11.024. Epub 2015 Dec 17. No abstract available.

PMID:
26715554
14.

[Research on blood estrogens and 17-ketosteroids in women in 4 cases of metastatic cancer of the breast].

BENARD H, COSTE F, PIGUET B, SEEMAN A.

Ann Endocrinol (Paris). 1962 Mar-Apr;23:133-44. French. No abstract available.

PMID:
13867024
15.

Progesterone--promoter or inhibitor of breast cancer.

Kuhl H, Schneider HP.

Climacteric. 2013 Aug;16 Suppl 1:54-68. doi: 10.3109/13697137.2013.768806. Epub 2013 Feb 20. Review.

PMID:
23336704
16.

Content, Readability, and Understandability of Dense Breast Notifications by State.

Kressin NR, Gunn CM, Battaglia TA.

JAMA. 2016 Apr 26;315(16):1786-8. doi: 10.1001/jama.2016.1712. No abstract available. Erratum in: JAMA. 2016 Jun 21;315(23):2624.

PMID:
27115382
17.

Elusive estrogens may hold key to some cancer risk.

Holzman D.

J Natl Cancer Inst. 1995 Aug 16;87(16):1207-9. No abstract available.

PMID:
7563162
18.

Mammographic density as a mediator for breast cancer risk: analytic approaches.

VanderWeele TJ, Adami HO, Tamimi RM.

Breast Cancer Res. 2012 Jul 26;14(4):317. doi: 10.1186/bcr3157.

19.

Fiber and breast cancer: another piece of the puzzle--but still an incomplete picture.

Gerber M.

J Natl Cancer Inst. 1996 Jul 3;88(13):857-8. No abstract available.

20.

[Estrogens, progesterones and the mammary gland].

Heikinheimo O.

Duodecim. 2005;121(5):525-32. Review. Finnish. No abstract available.

PMID:
15839154
Items per page

Supplemental Content

Write to the Help Desk